Objectives Use of corticosteroids is common in the treatment of coronavirus disease 2019,
but clinical effectiveness is controversial. We aimed to investigate the association of …

Background: Severe coronavirus disease 2019 (COVID-19) can boost the systematic
inflammatory response in critically ill patients, causing a systemic hyperinflammatory state …

Background Early descriptions of the coronavirus outbreak showed a lower prevalence of
asthma and COPD than was expected for people diagnosed with COVID-19, leading to …

Corticosteroids use in coronavirus disease 2019 (COVID-19) is controversial, especially in
mild to severe patients who do not require invasive/noninvasive ventilation. Moreover, many …

Background The effect of inhaled corticosteroid (ICS) on the risk of severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2) infection is unclear. Methods We performed a …

Inhaled corticosteroids have received substantial interest as treatments for non-hospitalised
patients presenting with symptomatic SARS-CoV-2 infections, following two open label …

The unprecedented coronavirus disease (COVID) pandemic is rapidly taking its toll on the
world population, health-care systems and workers, and global resources. Treatment …

Objective: With emerging of observational evidence, we aimed to perform a meta-analysis to
summarize the overall effect of the chronic use of inhaled corticosteroids on the clinical …

Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …